Recent hip fracture trends in Sweden and Denmark with age-period-cohort effects by Rosengren, B E et al.
Syddansk Universitet
Recent hip fracture trends in Sweden and Denmark with age-period-cohort effects
Rosengren, B E; Björk, J; Cooper, C; Abrahamsen, Bo
Published in:
Osteoporosis International
DOI:
10.1007/s00198-016-3768-3
Publication date:
2017
Document version
Final published version
Document license
CC BY-NC
Citation for pulished version (APA):
Rosengren, B. E., Björk, J., Cooper, C., & Abrahamsen, B. (2017). Recent hip fracture trends in Sweden and
Denmark with age-period-cohort effects. Osteoporosis International, 28(1), 139–149. DOI: 10.1007/s00198-016-
3768-3
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 19. Apr. 2017
ORIGINAL ARTICLE
Recent hip fracture trends in Sweden and Denmark
with age-period-cohort effects
B. E. Rosengren1,2 & J. Björk3 & C. Cooper4 & B. Abrahamsen2,5
Received: 11 May 2016 /Accepted: 6 September 2016 /Published online: 19 September 2016
# The Author(s) 2016. This article is published with open access at Springerlink.com
Abstract
Summary This study used nationwide hip fracture data from
Denmark and Sweden during 1987–2010 to examine effects
of (birth) cohort and period.We found that time trends, cohort,
and period effects were different in the two countries. Results
also indicated that hip fracture rates may increase in the not so
far future.
Introduction The reasons for the downturn in hip fracture
rates remain largely unclear but circumstances earlier in life
seem important.
Methods We ascertained hip fractures in the populations
≥50 years in Denmark and Sweden in national discharge reg-
isters. Country- and sex-specific age-period-cohort (APC) ef-
fects during 1987–2010 were evaluated by log-likelihood es-
timates in Poisson regression models presented as incidence
rate ratios (IRR).
Results There were 399,596 hip fractures in SE and 248,773
in DK. Age-standardized hip fracture rate was stable in SE
men but decreased in SE women and in DK. Combined peri-
od + cohort effects were generally stronger in SE than DK and
in women than men. IRR per period ranged from 1.05 to 1.30
in SE and 0.95 to 1.21 in DK. IRR per birth cohort ranged
from 1.07 to 3.13 in SE and 0.77 to 1.67 in DK. Relative
period effects decreased with successive period in SE and
described a convex curve in DK. Relative cohort effects in-
creased with successive birth cohort in both countries but with
lower risks for DK women and men and SE women born
around the 1930s (age 75–86 years today and responsible
for most hip fractures) partly explaining the recent downturn.
Men and women born thereafter however seem to have a
higher hip fracture risk, and we expect a reversal of the present
decline in rates, with increasing hip fracture rates in both
Denmark and Sweden during the upcoming decade.
Conclusions Time trends, cohort, and period effects were dif-
ferent in SE and DK. This may reflect differences in general
health as evident in known differences in life expectancy,
healthcare organization, and prevention such as use of anti-
osteoporosis drugs. Analyses indicate that hip fracture rates
may increase in the not so far future.
Keywords Age-period-cohort . Hip fracture . Men .
Trends . Women
Introduction
Hip fractures due to osteoporosis are overwhelmingly a dis-
ease of the industrial world, with fracture rates increasing pro-
portionally with gross domestic income and education level
across countries and with increasing rates and increasing
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female-to-male ratio as nations gradually adopt a Western,
industrial lifestyle [1].
During the past one or two decades, however, a break in the
increasing trend has been seen in most parts of the Western
world [2] including Scandinavia [3–6] with stable—or even
decreasing—hip fracture rates.
The many studies highlighting this downturn have not been
followed by an equal interest in identifying the responsible
mechanism, and many have been satisfied by the coinciding
advent and rise of antiresorptive osteoporosis treatment [7], a
notion not supported by other studies [6, 8].
The reasons for the recent changes remain largely unclear,
and while current efforts are important (such as antiresorptive
osteoporosis treatment), also, circumstances earlier in life
seem essential as evident in previous studies investigating
differences in hip fracture risk between birth cohorts [7,
9–13]. The origin of the changes in hip fractures is particularly
challenging to unravel because of their peak incidence late in
life and the consequent need for explanatory models to access
information about societal, and preferably individual, expo-
sures as early as five to eight decades earlier [14], a point in
time where national health and lifestyle surveys were few and
far apart.
Denmark (DK) and Sweden (SE) are neighboring northern
European countries with very high rates of fragility fractures
[15]. We have previously examined hip fracture incidence
separately for both countries [5, 6] but now set out to examine
more recent incidence and time trends as well as age-period-
cohort effects in the two countries using identical
methodology.
Methods
We studied the entire populations aged ≥50 years from year
1980 to 2010 in DK and 1987 to 2011 in SE in discharge data
from the registries of the National Board of Health and
Welfare in each country. Each year, patients with an acute
hip fracture were identified using the diagnosis code for prox-
imal femoral fracture as well as a relevant surgical procedural
code (Online Resource 1). For estimation of the population at
risk, we acquired annual population data for men and women
aged ≥50 years in 1-year age bands for the entire observation
period from Statistics Sweden and Statistics Denmark (gov-
ernment authorities for official statistics including all inhabi-
tants in each country).
During the study periods, major changes in the population
≥50 years were evident. In Denmark, the annual population
≥50 years was about 1.6 million in between 1980 and 1987
rising to 2 million in 2010 (53 million person years) and in
Sweden from 2.8 to 3.5 million from 1987 to 2011 (79 million
person years). The expected survival at age 50 also increased
in both countries. Hence, residual life expectancy increased
from 32 to 35 years in women and from 28 to 31 years in men
in Sweden (Statistics Sweden) and from 30 to 33 (women) and
25 to 29 (men) in Denmark (Statistics Denmark). The age
distribution in both women and men age ≥50 years in both
countries underwent marked changes during the study period
(Online Resource 2).
We used national inpatient data for individuals aged
≥50 years in Denmark during 1980–2010 and in Sweden dur-
ing 1987–2011 to examine annual numbers and incidence
rates of hip fractures. During the years where data were avail-
able for both countries, i.e., 1987–2010, we evaluated age-
period-cohort effects by log-likelihood estimates in Poisson
regression models. This approach was introduced by
Clayton and Shifflers [16, 17] and Hollford [18] and has been
described in detail previously [12]. The models were fitted to
gender- and nation-specific hip fracture data of Swedish and
Danish men and women age 50–97 years 1987 to 2010 using
4-year age and period intervals and 8-year intervals for cohort
(starting at every fourth year and hence overlapping), yielding
12 different age groups, 6 time periods, and 17 birth cohorts.
The rationale for using 8-year (birth) cohort classes while
4-year classes are used for age and period is to make sure that
all persons that belong to a certain age class during a particular
period at the same time also belong to the same cohort class.
To make this happen, the length of the cohort class must be
twice the length of the age and period classes (please see
Online Resource 3 and Table 2 (including the footnote) for
further explanation). By decomposing the effect parameters of
the general APC model, it can be shown that the (log) linear
trends (Bdrifts^) of the three components age, period, and
cohort cannot be separated. This means for example that linear
trends over calendar time cannot be unambiguously distin-
guished from linear trends over birth cohort, i.e., period effects
are inherent in cohort effects and vice versa. However, devia-
tions from the underlying linear trends (Bcurvatures^) can be
estimated separately for period and cohort effects (i.e., relative
differences between different cohorts or different periods) [18,
19].We set the cohort effects of the two youngest birth cohorts
(1949–1956 and 1953–1960) to zero in order to make estima-
tion of the APC model parameters possible. We limited the
APC analysis to age 97 years to avoid statistical instability as
available population statistics were aggregated from age
100 years rendering population data for older age strata (98–
101 years and older) unreliable.
Age adjustment was done by direct standardization with
the mean total population of both countries during 1987–
2010 as reference, time-trend analysis by linear regression,
and identification of breakpoints in linear trends by join-
point analysis (Joinpoint Regression Program, Version 4.0.4.
May 2013; Statistical Research and Applications Branch,
National Cancer Institute, USA). The study was approved
by Statistics Denmark (project reference 703857) and the
ethics committee at Lund University, Sweden (2012/394).
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Results
During the examined years, there were 399,596 hip frac-
tures in SE (72 % in women) and 248,773 in DK (74 % in
women). The overall hip fracture rates (≥50 years) per
10,000 person years during 1987–2010 (where data were
available for both countries) were 55 in SE (32 in men and
74 in women) and 49 in DK (28 in men, 68 in women). As
DK rates 1995 (low) and 1996 (high) stood out compared
to other DK years, coinciding with the change from ICD-8
to ICD-10 which may have led to recoding in the transi-
tion years, we henceforth used the crude 2-year incidence
1995–1996 (in 1-year age classes) to estimate the annual
incidence for each of these 2 years and to estimate annual
numbers.
Generally, the join-point analysis showed that the overall
annual number of hip fractures (≥50 years) increased in both
men and women in both SE and DK until the mid-1990s
whereafter the numbers decreased in both Swedish and
Danish women (−0.5 %[95 % CI −0.7, −0.2] respective
−1.8 %[−2.3, −1.3]), were stable in Danish men
(+0.1 %[−0.3, 0.6]), and increased in Swedish men (+1.3 %
per year [0.9, 1.7]); details are presented in Fig. 1 and Online
Resource 4.
The overall annual age-standardized rate (≥50 years) for
Swedish men increased from 1987 to 1996 followed by a
decrease until 2000 whereafter the rate was stable (−0.4 %
[95 % CI −0.8, 0.1]). For Swedish women, the rate was stable
until 1999 whereafter a decrease (−1.3 % [−1.6, −1.0]) was
evident. In DK, rates increased in both men and women until
2001 respective 1997 whereafter decreases were evident in
both genders (−1.8 % [−2.4, −1.2] respective −3.1 %[−4.0,
−2.1]); details are presented in Fig. 1 and Table 1.
Age-, period-, and cohort-specific hip fracture data are pre-
sented in Table 2. Birth cohorts (per 8-year stratum) can be
followed diagonally from left to right in the table. As an ex-
ample, individuals aged 50–53 years old during the first peri-
od (1987–1990) were born during 1933–1940 (top left col-
umn of the table) and are shaded in the table. The same indi-
viduals were during the next period (1991–1994) 54–57 years
old and can be found one row down and one column to the
right from the top left column. Relevant model building details
are presented in Online Resource 5 where it can be seen that
the full APC model provided the best fit for both men and
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Fig. 1 Annual age-standardized
hip fracture rate (per 10,000) and
number of hip fractures in Danish
and Swedish men and women
(Denmark year 1980 to 2010 and
Sweden 1987 to 2011). By direct
standardization with the mean to-
tal population of both countries
during the observation years
1987–2010 as reference
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women in both SE and DK (by comparing the deviance be-
tween adjacent modeling steps).
Results from AC- and AP-models are presented in Table 3.
Note that both models estimate the sum of period and cohort
effects. When stratified by cohort (in the AC models), these
combined effects were noticeably stronger in SE than DK and
in women than men.
Incidence rate ratios (IRR) per period in the AP models
ranged from 1.05 to 1.30 in Swedish women, 1.03 to 1.15 in
Swedish men, 1.11 to 1.21 in Danish women, and 0.95 to 1.11
in Danish men.
The corresponding IRR per birth cohort in the AC models
ranged from 1.16 to 3.13 in Swedish women, 1.07 to 1.61 in
Swedish men, 1.06 to 1.67 in Danish women, and 0.77 to 1.14
in Danish men.
In the APC models, relative period effects (actual relative
differences between periods without any interfering cohort
effects) decreased with successive period for men and women
in SE and described a convex curve for both men and women
in DK with higher than expected risk in the periods in the
middle of the examination years (Fig. 2).
Relative cohort effects (actual relative differences between
cohorts without any interfering period effects) increased with
successive birth cohort for both genders in both countries but
with markedly lower relative risks for Danish women born in
1929–1952 and Danish men born in 1925–1944, and lower
relative risks for Swedish men born in 1933–1948 and
Swedish women born in 1933–1944 (Fig. 2).
Discussion
In this study of nationwide hip fracture data in Sweden
and Denmark during up to 31 years, decreasing or stable
age-standardized rates were evident in both genders and in
both countries during the most recent decade. This was
accompanied by a decreasing annual number of hip frac-
tures in women (both SE and DK), stable numbers in
Table 1 Time trends in annual age-standardized hip fracture rate in Sweden and Denmark presented as annual percent (%) change between
breakpoints
Age span Men Women
Breakpoint Period Annual percent change Breakpoint Period Annual percent change
Sweden
≥50 1987–1996 + 0.8* (0.2, 1.4) 1987–1996 −0.4 (−0.8, 0.0)
1996 1996–2000 −3.4* (−6.5, −0.2) 1996 1996–1999 −3.7 (−8.1, 0.8)
2000 2000–2011 −0.4 (−0.8, 0.1) 1999 1999–2011 −1.3*(−1.6, −1.0)
50–79 1987–1996 + 0.4 (−0.2, 0.9) 1987–1993 −0.8 (−1.9, 0.3)
1996 1996–2001 −3.5* (−5.3, −1.8) 1993 1993–2011 −2.1*(−2.3, −1.9)
2001 2001–2004 + 1.2 (−4.5, 7.1)
2004 2004–2011 −1.5* (−2.2, −0.7)
≥80 1987–1996 + 1.2*(0.5, 1.9) 1987–1996 −0.1 (−0.5, 0.4)
1996 1996–1999 −4.3 (−11.0, 2.8) 1996 1996–1999 −3.6 (−8.6, 1.7)
1999 1999–2011 −0.1 (−0.5, 0.3) 1999 1999–2011 −1.1*(−1.4, −0.8)
Denmark
≥50 1980–1989 + 4.5* (3.9, 5.2) 1980–1984 + 1.5* (0.1, 3.0)
1989 1989–2001 + 1.2* (0.8, 1.7) 1984 1984–1987 + 5.1* (0.4, 9.9)
2001 2001–2010 −1.8* (−2.4, −1.2) 1987 1987–1997 + 0.6* (0.2, 1.0)
1997 1997–2005 −1.1* (−1.7, −0.5)
2005 2005–2010 −3.1* (−4, −2.1)
50–79 1980–1988 + 3.8* (2.6, 4.9) 1980–1991 + 2.6* (2.0, 3.2)
1988 1988–2001 + 0.8* (0.2, 1.5) 1991 1991–2005 −1.0* (−1.4, −0.5)
2001 2001–2010 −1.4* (−2.3, −0.5) 2005 2005–2010 −3.7* (−5.7, −1.8)
≥80 1980–1991 + 5.2* (4.5, 5.8) 1980–1991 + 2.5* (2.1, 3.0)
1991 1991–2001 + 1.3* (0.4, 2.1) 1991 1991–2002 + 0.0 (−0.5, 0.5)
2001 2001–2010 −1.9* (−2.8, −1.1) 2002 2002–2010 −2.4* (−3.1, −1.7)
*A statistically significant change
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Danish men, and increasing numbers in SE men. The com-
bined period and cohort effects were generally stronger in
SE than DK and in women than men. Relative cohort
effects (actual relative differences between cohorts
without any interfering period effects) increased with suc-
cessive birth cohort for both genders in both countries but
with markedly lower relative risks for Danish women born
in 1929–1952 and Danish men born in 1925–1944 and
Table 2 Hip fracture rate per 4-year period (from year 1987 to 2010) and 4-year age stratum (from age 50 to 97 years) in Sweden and Denmark. Birth
cohorts (per 8-year stratum) can be followed diagonally from left to right in the table
Sweden Denmark
Hip fracture rate (per 10,000)
per 4-year period
Hip fracture rate (per 10,000) 
per 4-year period
1987
1990
1991
1994
1995
1998
1999
2002
2003
2006
2007
2010
1987
1990
1991
1994
1995
1998
1999
2002
2003
2006
2007
2010
Men
50 53 4 4 3 3 3 3 3 4 4 4 5 4
54 57 5 5 5 4 5 4 5 5 5 6 7 7
58 61 8 8 7 6 7 6 7 8 7 9 8 9
62 65 12 12 12 10 10 10 12 11 12 12 11 12
66 69 18 19 19 16 16 14 18 17 17 20 19 17
70 73 29 31 31 27 27 24 28 32 30 28 28 27
74 77 53 51 53 48 46 43 48 51 55 54 46 45
78 81 86 92 92 81 82 78 71 84 86 88 85 70
82 85 146 146 156 134 137 132 116 133 142 144 143 130
86 89 219 225 230 214 213 212 176 204 213 219 217 203
90 93 319 326 324 309 307 305 244 265 307 307 297 287
94 97 369 437 397 400 392 422 376 379 400 428 339 349
Women
50 53 4 3 3 3 3 2 5 4 4 4 4 4
54 57 8 6 6 5 5 4 9 7 7 6 6 7
58 61 13 12 10 8 8 8 15 13 12 9 11 11
62 65 19 19 16 13 13 13 21 21 19 17 16 16
66 69 31 30 28 26 24 20 34 35 35 30 30 24
70 73 54 53 51 45 45 38 55 57 59 55 51 43
74 77 98 96 88 82 76 72 91 98 97 95 90 77
78 81 167 169 156 139 135 123 149 155 157 159 149 131
82 85 266 265 260 228 213 210 235 246 249 247 227 213
86 89 381 371 364 335 319 304 343 361 367 361 336 304
90 93 455 461 450 421 415 394 418 469 454 455 446 400
94 97 485 488 465 444 445 468 495 548 537 525 509 472
In the year 1987, individuals who were 50 years old were born in 1937 (or 1936 if they not had their 51st birthday yet) and individuals whowere 53 years
old were born in 1934 (or 1933 if they had not had their 54th birthday yet). In the year 1990, individuals who were 50 years old were born in 1940 (or
1939 if they not had their 51st birthday yet) and individuals whowere 53 years old were born in 1937 (or 1936 if they had not had their 54th birthday yet).
Consequently, individuals who were 50–53 years old during the period 1987–1990 were born between 1933 and 1940 and are located at the top left
column during 1987–1990. This birth cohort can be followed diagonally in the table and is shaded for clarity
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lower relative risks for Swedish men born in 1933–1948
and Swedish women born in 1933–1944.
Looking at the APC results from another perspective, it is
clear that the individuals currently around the mean age of hip
fracture (age 75–86 years; Fig. 2, shaded cohorts) have lower
relative risks than expected. This may partly explain the cur-
rent downturn in hip fracture rates but also has implications
for the future as more recently born cohorts (currently youn-
ger) have higher relative risks and during the next decade will
replace their older counterparts in contribution to the number
of hip fractures. Based on this, it is reasonable to expect in-
creasing hip fracture rates in both DK and SE during the up-
coming decades, particularly if no future counteracting period
effects are seen. Together with the increasing number of old
and very old individuals in the population, this may result in a
substantially higher annual number of hip fractures in the not
so far future.
The fracture probability for an individual at a given
time point may be estimated by risk factors such as bone
mineral density (BMD), previous fractures, fall risk, co-
morbidities, and medications as in FRAX®. These preva-
lent risk factors however depend on both genetics and
prior environmental exposure, sometimes very early in life
[14]. The fetal programming hypothesis [20] states that
abnormal fetal growth is associated with a number of
chronic conditions apparent only later in life [21, 22].
Such a pattern has been found also for BMD in SGA
(small for gestational age) premature children who devel-
op normal BMD until puberty, but a deficit in the pubertal
growth spurt and a low peak bone mass (PBM) [23] and
for children with low growth rate and increased hip frac-
ture risk [24]. During the more than 100-year-lived history
of the individuals in this analysis, both DK and SE have
gradually developed into welfare states and the living
Table 3 Birth cohort effects from age-cohort (AC) models and calendar period effects from age-period (AP) models presented as IRR (incidence rate
ratios) with 95 % confidence intervals in comparison with the respective reference (REF) birth or period cohort. Note that period effects are inherent in
the cohort effects of the AC model and vice versa
Swedish men Danish men Swedish women Danish women
IRR (95 % CI) IRR (95 % CI) IRR (95 % CI) IRR (95 % CI)
Birth cohort
Birth cohort effects from age-cohort (AC) models
1889–1896 1.42* (1.05 to 1.91) 0.85 (0.56 to 1.31) 3.13* (2.30 to 4.27) 1.59* (1.03 to 2.45)
1893–1900 1.61* (1.27 to 2.04) 0.77 (0.55 to 1.08) 3.10* (2.31 to 4.15) 1.62* (1.09 to 2.40)
1897–1904 1.56* (1.24 to 1.96) 0.79 (0.58 to 1.08) 3.10* (2.32 to 4.14) 1.67* (1.13 to 2.47)
1901–1908 1.57* (1.26 to 1.97) 0.86 (0.63 to 1.16) 3.00* (2.24 to 4.00) 1.66* (1.13 to 2.44)
1905–1912 1.55* (1.24 to 1.94) 0.87 (0.65 to 1.18) 2.92* (2.19 to 3.90) 1.66* (1.13 to 2.44)
1909–1916 1.58* (1.26 to 1.97) 0.92 (0.69 to 1.24) 2.84* (2.13 to 3.79) 1.63* (1.11 to 2.40)
1913–1920 1.49* (1.19 to 1.86) 0.93 (0.69 to 1.25) 2.62* (1.97 to 3.50) 1.59* (1.08 to 2.34)
1917–1924 1.46 *(1.17 to 1.83) 0.95 (0.71 to 1.28) 2.43* (1.82 to 3.24) 1.54* (1.05 to 2.26)
1921–1928 1.43* (1.14 to 1.78) 0.92 (0.68 to 1.23) 2.33* (1.75 to 3.11) 1.52* (1.03 to 2.23)
1925–1932 1.35* (1.09 to 1.69) 0.82 (0.61 to 1.10) 2.14* (1.61 to 2.86) 1.45 (0.99 to 2.12)
1929–1936 1.28* (1.02 to 1.60) 0.87 (0.65 to 1.17) 2.04* (1.53 to 2.72) 1.32 (0.90 to 1.93)
1933–1940 1.20 (0.96 to 1.50) 0.87 (0.65 to 1.16) 1.74* (1.31 to 2.32) 1.20 (0.82 to 1.75)
1937–1944 1.11 (0.89 to 1.38) 0.86 (0.64 to 1.14) 1.54* (1.15 to 2.06) 1.06 (0.72 to 1.56)
1941–1948 1.10 (0.88 to 1.37) 0.93 (0.69 to 1.23) 1.49* (1.12 to 1.99) 1.07 (0.73 to 1.57)
1945–1952 1.09 (0.87 to 1.37) 1.001 (0.75 to 1.34) 1.35* (1.01 to 1.81) 1.07 (0.72 to 1.57)
1949–1956 1.07 (0.85 to 1.36) 1.14 (0.85 to 1.55) 1.16 (0.85 to 1.58) 1.12 (0.75 to 1.69)
1953–1960 1 (REF) 1 (REF) 1 (REF) 1 (REF)
Calendar period
Calendar period effect from age-period (AP) models
1987–1990 1.12* (1.08 to 1.16) 0.95 (0.90 to 1.004) 1.30* (1.26 to 1.35) 1.16* (1.11 to 1.20)
1991–1994 1.15* (1.11 to 1.18) 1.05 (0.99 to 1.10) 1.28* (1.24 to 1.33) 1.21* (1.16 to 1.25)
1995–1998 1.15* (1.12 to 1.19) 1.08*(1.02 to 1.14) 1.22* (1.18 to 1.26) 1.20* (1.16 to 1.25)
1999–2002 1.03* (1.002 to 1.07) 1.11*(1.05 to 1.17) 1.10* (1.06 to 1.14) 1.17* (1.13 to 1.22)
2003–2006 1.04* (1.004 to 1.07) 1.07*(1.01 to 1.12) 1.05* (1.02 to 1.09) 1.11* (1.07 to 1.15)
2007–2010 1 (REF) 1 (REF) 1 (REF) 1 (REF)
*A statistically significant difference from reference birth cohort (born 1953–1960) or period (year 2007–2010)
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circumstances have undergone major changes. As a gen-
eral index of better population health, life expectancy at
birth has increased.
In many aspects, the population at risk during the later
years of the examination period seems healthier in general
[25] with a lower prevalence of common diseases [26–28]. It
has been suggested that such a healthy population may also,
perhaps paradoxically, include more old and frail individuals
saved from events which in the past they would not have
survived [11]. An increased co-morbidity in US hip fracture
patients was registered for the period 1986–2005 consistent
with such a mechanism [29].
Theoretically, peak bone mass is a more important factor
than bone loss rates—it is estimated that it would take 28 years
for a person who lost bone at a rate 1 SD above normal to
offset an advantage of having peak bone mass 1 SD above
mean [30]. Unfortunately, measurement of BMD has had to
wait for the development of appropriate technology and long-
term time trends of peak bone mass are therefore not known.
Older, scarce data on time trends of BMD in adult or aged
cohorts are available for SE (stable BMD from years 1988/
1989 to 1998/1999) [31, 32] but none for DK. A recent study
from the nearby country of Finland however found increasing
BMD in elderly women from year 2002 to 2010 [33], some-
thing that previously has been indicated also in the USA
(NHANES III 1988/94 to 2005–2008) [34]. In an examination
of a non-population-based register of Canadian BMD data in
women (from year 1996 to 2006), the decreasing fracture rates
were attributed to a secular increase in BMD rather than anti-
osteoporotic treatment and increase in BMI [35].
Time trends for many measurable indicators important for
fracture risk including BMI, BMD, nativity, smoking, exer-
cise, nutrition (including calcium and vitamins), and alcohol
consumption are important but also difficult to unravel. In
both SE and DK, BMI as well as the proportions of obese
and overweight individuals in both women and men have
increased, at least to the advent of the new millennium [36,
37], and BMI is now fairly similar in the two countries [38].
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Fig. 2 Estimation of departure
from linearity for birth cohort
effects and period effects for age-
period-cohort (APC) models in
Swedish and Danish men and
women. Note that, because there
is a linear relationship among year
of birth, year of hip fracture, and
age at hip fracture (i.e., if any two
are known, then the third can be
calculated), the individual birth
cohort effects from the APC
model do not necessarily have an
interpretation in terms of relative
risk (in contrast to the combined
period-cohort effects derived
from the AC or AP models in
Table 3)
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During the examination period, osteoporosis became official-
ly recognized and defined by the WHO [39], case finding
strategies were developed, and pharmacologic treatment be-
came increasingly available. Even though this coincides with
the secular decrease in hip fracture rate, the effect on overall
hip fracture risk in the population has in ecological data been
found to be low (in DK <5 %) [6], at least compared to effects
originating from the progressive increase in BMI (in DK +25–
50 %) [6].
Trends in HRT prescription may also have influenced frac-
ture risk. The prevalence of HRT use in Sweden decreased
from a peak of 36 % in women aged 50–59 years in 1999 to
9 % in 2007 [40]. This rapid change in treatment strategy may
have resulted in cohort effects as exemplified in DK by
Løkkegaard et al. [41], but would not exert any influence on
male fracture risk. Thiazides, beta-blockers, calcium channel
blockers, and ACE inhibitors also decrease fragility fracture
risk [42, 43], and increase in usage over time may thus reduce
hip fracture burden.
Many aspects of childbirth may be important for bone
health. Birth weight for example seems important for peak
BMC [44], even though a Swedish study could not find any
association to adult fracture risk in a cohort of women and
men born in the year 1915–1929 [45]. Nationwide birth
weight data for the birth cohorts in our study are not available
for Sweden or Denmark. However, if results from the large
Danish Copenhagen School Health Records Register can be
extended to the rest of the country, then birth weight has been
remarkably stable over the five decades from 1930 to 1984
[21]. Neither DK nor SE has been struck by famine but DK
was during WWII occupied while Sweden remained autono-
mous; the implications are however difficult to appreciate but
a study found little impact on anthropometrics in Swedish and
Danish children, at least compared to those in Finland and
especially Norway [46].
Differences in elderly care between DK and SE may also
contribute to disparity in hip fracture risk. In 2007, for exam-
ple, 22 % of DK individuals ≥80 years were institutionalized
compared to only 16 % in Sweden [47, 48], where extensive
home care has become targeted more at people with a higher
dependency [49]. In Denmark, an offer of preventative home
visits to all citizens aged ≥75 years becamemandatory in 1996
[50], which may provide better identification of those in need
of extended care and institutionalization in DK than SE.
Vitamin D fortification policy has been different in SE and
DK. In DK, vitamin D fortification of margarine was manda-
tory in 1961–1985 and fortification of low-fat milk was per-
mitted between 1972 and 1976. In Sweden, fish liver oil (with
high vitamin D content) was recommended to all infants from
1940 onwards, later replaced by drops of vitamins A and D.
After World War II, vitamin D was also added to dairy prod-
ucts such as milk and margarine in Sweden at varying levels
[51]. Currently, only low-fat dairy and margarine products are
fortified. The impact on hip fracture risk of these differences is
difficult to appreciate. It should also be mentioned that the
prevalence of hip arthroplasty in society may affect the num-
ber of hip fracture as a total hip arthroplasty protects from hip
fracture. A recent study from the USA found a 5 % prevalence
of total hip arthroplasty in individuals aged 80 years with a
substantial rise in recent years [52].
Even though APC models are commonly used in, for ex-
ample, cancer research, only few studies have used the ap-
proach for hip fractures trends [7, 9–13]. The results are diffi-
cult to compare as they rely on different assumptions and
constraints to address the identifiability problem, i.e., to sepa-
rate the effect of the three entangled factors age, period, and
cohort. We chose to use the most recent cohorts as reference as
this undoubtedly makes appreciation of recent trends easier. In
this, as in our previous study of APC effects of Swedish hip
fracture data year 1987 to 2002 [12], we used annual official
population statistics in 1-year age classes and not extrapola-
tion of census data as others have [7].
Samelson et al. [10] tabulated hip fracture data from year
1948 to 1995 by birth cohort in a small cohort (n = 5209) of
men and women born in year 1887 to 1921. Although the
results are noteworthy, the method does not enable separation
of the two entangled factors birth cohort and period which
substantially blunts the inferences. Evans et al. [9] were the
first to use an APC model for hip fracture and used admission
data (England andWales year 1968–1986; 55,261 admissions;
born year 1860–1919). Unorthodox age and birth cohort strat-
ification, drift analysis as a single factor, and now outdated
birth cohorts and period of examination (not covering recent
changes in hip fracture rates) render inferences less interesting
today. Langley et al. [11] examined hip fracture discharge data
in New Zeeland during an impressive time frame of 1974–
2007 in individuals born in 1873–1957. In the same way as
we, they allowed sliding in age by period (and vice versa) by
utilizing double cohort length to handle the separation prob-
lem. Results and inferences are striking but are difficult to set
in perspective as they are drawn under the influence of the
intrinsic estimator (IE) model, a postulated method for han-
dling the identifiability problem. Jean et al. [13] recently pub-
lished interesting APC inferences drawn from Canadian dis-
charge data year 1985–2005. The results are difficult to inter-
pret since hospitalization for hip fracture (n = 570,872) was
the only case selector and the recommended sliding in age
during periods (and vice versa) [16–18] was inhibited by use
of equal period, age, and birth cohort spans. Alves et al. [7]
evaluated APC effects in Portuguese nationwide discharge
data year 2000–2008 with hospitalization for hip fracture as
case selector (n = 77,083). Even though they utilized very
narrow age, period, and cohort spans, they, like Jean et al.
[13], used equal spans. They did however add a novel ap-
proach with generalized additive models (GAM) to identify
non-linear effects of age, period, and cohort through spline
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functions. They found a temporal coincidence of a non-
significantly higher birth cohort hip fracture risk and
economically/politically unstable periods.
The strengths of our study include the evaluation of hip
fractures in adults (age ≥ 50 years) in two complete neighbor-
ing countries during up to 31 years with central official data on
annual population at risk, inclusion of hip fractures from cen-
tral official registers (used also for reimbursement of care
givers), and strict hip fracture definition (through diagnosis
records as well as surgical procedure records). The case find-
ing strategy reduces problems with transitions between diag-
nosis classification systems (prevalent in Sweden from ICD-9
to ICD-10 and in Denmark from ICD-8 to ICD-9) as codes are
not fully equivalent between systems and may lead to a clas-
sification bias, which we sought to reduce to a minimum by
also using surgical procedure codes. Any transition, which
may be a period in time when some practitioners are still
unused to the new set of codes and local/central administration
of registration lags behind, can make a temporary impact in
number of events as evident in DK for both men and women
in 1995/1996; we addressed this problem by utilizing the 2-
year incidence to estimate the number of fractures each year.
In the APCmodel, these years were in the same period (1995–
1998), and the approach was consequently irrelevant for anal-
yses results.
Weaknesses include the inherit limitations of the APC
model and in this perspective the relatively short follow-up
period of only 24 to 31 years. Because of the linear relation-
ship among age, period, and cohort (i.e., if two factors are
known, the third is determined), the period and cohort effects
in APC models cannot truly be statistically separated. In the
current models, effects of immigration have not been taken
into account which may affect the results [53]. Future studies
will improve estimates for younger birth cohorts and should
include patient-specific data on other important factors should
be included, i.e., bone traits, anthropometry, birth weight,
apgar score, diseases, medication, etc. With the exception of
the Copenhagen area [21], there is no universal source of birth
weight data in Denmark for individuals born before 1974, and
this population is of course still much too young to provide
information on hip fracture outcomes.
Conclusion
In Denmark and Sweden, earlier trends with decreasing age-
standardized hip fracture rates continued during the recent
decade except for Swedish men where the rate was stable.
The magnitude of the period and cohort effects suggests mul-
tiple factors are contributing. Temporal trends as well as gen-
der and national differences may be attributable to disparity in
lifestyle as well as changes in hormone-replacement or anti-
osteoporosis therapy. This should be examined in large
international collaborative studies with in-detail patient-spe-
cific data. Following from the results of the current analyses,
we expect a reversal of the present decline in rates, with in-
creasing hip fracture rates in both Denmark and Sweden dur-
ing the upcoming decade.
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